AbbVie

ABBV

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

AbbVie has been a target of short sellers for a while. The current short interest of 1.10% is roughly at the average of the last 12 months (1.17%).